Introduction: Managing anemia in pediatric cancer patients

Medical and Pediatric Oncology

Volumn 39, Issue 4, 2002, Pages 446-447

  Vote, P A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Anemia; Chemotherapy complications; Childhood cancer; Epoetin alfa; Pediatric

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CANCER PATIENT; CHILDHOOD CANCER; CHRONIC DISEASE; CONFERENCE PAPER; ERYTHROCYTE TRANSFUSION; PEDIATRICS; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT PLANNING;

ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD WELFARE; ERYTHROPOIETIN; HUMANS; NEOPLASMS;

EID: 0036779813     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10182     Document Type: Conference Paper

References (21)

1. Hepatitis C infection among survivors of childhood cancer
2. Medical progress: Transfusion medicine (first of two parts)-blood transfusion
3. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer
4. Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck
5. Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer
6. Erythropoietin for anemia in cancer patients
7. Clinical application of recombinant erythropoietin in anemic cancer patients
8. Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin
9. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
10. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
11. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
12. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing
13. Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma
14. Erythropoietin reduces volume of red cell transfusions required in some subsets of children with acute lymphocytic leukemia
15. Recombinant erythropoietin in acute chemotherapy-induced anemia of children with cancer
16. Prevention of anemia with r-HuEPO in children with Ewing's or osteogenic sarcoma
17. Treatment with recombinant human erythropoietin in children with malignancies
18. Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: A randomized double-blind, placebo-controlled trial
19. Recombinant human erythropoietin (rHuEPO) in children with cancer: A randomized study
20. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children
21. Reduction in transfusion requirements with early epoetin alfa treatment in pediatric patients with solid tumors: A case-control study